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METHODS & MATERIALS

Somatic dysfunction (SD) is defined as “impaired or
altered function of components relating to the somatic
(body framework) system: skeletal, arthrodial, and
myofascial structures related to the vascular,
lymphatic, and neural elements.” Tissue texture and
quality of end-feel motion are objective palpatory
findings used to identify spinal SD but these are often
difficult characteristics to quantify.

Baseline durometer and palpatory measures of the entire cervical
spine using Spineliner® and IsoTOUCH® systems were obtained in 265
subjects prior to OMT. Of these, a subpopulation (n=31) was identified
for a single NMM/OMM specialty physician (MLK) in which the OA was
both diagnosed as the “key SD” and treated with HVLA. OMT.
Complete data was available for analysis from 25 in this group.

The Spineliner® System (Sigma Instruments;
Pittsburgh PA, USA) is a durometer capable of
analyzing and quantifying hysteresis and fixation at
various spinal levels by measuring deformation and
recoil tissue responses to a specific piezoelectric
impulse generated precisely at the end of a 4-pound
deformation pressure.

HYPOTHESES
1. Instrumented measures of palpatory pressures
and tissue texture changes used in diagnosing
SD of the occipitoatlantal (OA) region and its
treatment with high velocity low amplitude
(HVLA) thrust OMT are possible and quantifiable.
2. The pressure range for palpation will fall in the
tissue hysteresis range used by the
instrumentation.
3. Clinical measures of OMT efficacy will be
comparable to instrumented measures.
4. Cervical HVLA OMT involves a very low pressure
very short duration tissue impulse beyond the
first palpable sense of end-feel restriction.

Perceptions of OMT efficacy were interpreted from recorded palpatory
changes in assessed post-OMT SD severity values. Any audible
cavitation was also noted. The Spineliner® physician was always
blinded to the type of OMT used and cervical level treated.

Of 31 subjects with OA SD, 28 (90%) preferred the diagnosis of sidebending right, rotation left; 3 were
diagnosed with a sidebending left, rotation right SD.
IsoTOUCH® data analysis revealed similar overall segmental diagnostic palpatory pressures from OA to C7
vertebrae in this population. Preload averaged 1.35lbs (6.00N) (95%CI=1.31-1.40lbs [5.83N-6.23N]) with endfeel pressures averaging 2.64lbs (11.74N) (95%CI=2.56-2.72lbs [11.39-12.09N]). The average difference
between the preload and end-feel pressure was 1.31lbs (5.83N) (p<0.001) (see figure 3).
The overall treatment pressures for the OA SD averaged a preload pressure of 2.89lbs (12.86N) (95%CI=2.423.35lbs [10.76-14.90N]) and the final thrust pressures averaged 4.05lbs (18N) (95%CI=3.53-4.57lbs [15.7020.33N]). The actual HVLA activating force averaged 1.10lbs (4.89N) (95%CI=0.83-1.36lbs [3.69-6.05N]) with a
fractional-second duration. There was no significant difference between the end-feel diagnostic barrier and
the preload used to contact the SD barrier prior to HVLA OMT (see figure 3.)
During HVLA OMT, audible cavitations were appreciated by the treating physician in 80% of the subjects.
Manual physical re-examination by the treating physician after OMT was reported to show improved
palpatory motion characteristics in 84% of the subjects. By comparison, the independent durometer data
(by a blinded physician) documented an objective improvement of tissue texture changes for fixation
(resistance) in 76% of the subjects (see figure 4.)

DISCUSSION

IsoTOUCH® data was later abstracted to analyze palpatory pressures
used for preload and end-feel moments at the time of articular
sidebending and rotation diagnoses, manual pressures used to
engage “the SD restrictive barrier” prior to HVLA, and the additional
HVLA thrust pressure characteristics used during the OMT.
Spineliner® tissue texture data was independently abstracted to
analyze the percentage of OA SD showing statistically different fixation
measures post-OMT.

Figure 1: IsoTouch® palpation monitors in use

CONCLUSION
Consistent intraoperator OA-C7 palpatory pressures were documented
using IsoTOUCH® technology. Diagnostic tissue load averaged 1.35lbs
(6N); 1.31lbs (5.83N) added to assess barrier end-feel. Consistent OMT
pressure parameters were also documented for this singular form of
OA SD HVLA.
During the treatment, after reaching the SD barrier, the treating
physician employed an additional fractional-second force averaging
1.10lbs (4.89N) focused over occipital tissues. The preload over these
tissues immediately before the final thrust averaged less than 3lbs and
was essentially under 3.5lbs (15.57N) of pressure. Such parameters
remained consistent between the subjects, despite the variable cervical
tissue composition and musculature development.

Figure 2: IsoTOUCH® cervical diagnostic
palpation data recording
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The IsoTOUCH® (Neuromuscular Engineering LLC;
Nashville TN, USA) is a non-invasive, tactile pressure
sensor palpation monitoring system developed to
measure forces used in palpatory SD diagnosis and
its treatment with Osteopathic Manipulative Treatment
(OMT). Capacitance pressure sensors placed over
finger pads wirelessly transmit real-time data to a
computer (see figures 1-2.)

After placing the occiput of each subject into
slight flexion (using a loose-packed position
regardless of sagittal diagnosis) , a pre-load
pressure was applied with lateral translation
and sidebending to the SD barrier. A single
HVLA curvilinear force (introduced primarily
through a single third-digit fingertip placed over
the occiput) was directed at the SD barrier
towards the opposite orbit.

RESULTS
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Figure 3: Average difference in diagnostic and treatment
pressures. Also note that the diagnostic end-feel pressures
are consistent with the amount of pressure used to set-up
the tissues to the restrictive barrier prior to application of the
HVLA thrust.
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Figure 4: Patients with documented tissue
texture improvement (76%) measured
independently using a durometer. The treating
physician reported audible cavitation (80%) and
improvement in palpable motion changes (84%)
after treatment of OA SD using HVLA OMT.
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IsoTOUCH® technology appears capable
of quickly and consistently measuring
pressures used in the palpatory
diagnosis and treatment of SD.
Documentation of palpatory pressures
will facilitate reproduction of these or
similar techniques, helping to expand
the evidence base for manual medicine.
Furthermore, real-time feedback and
comparison capabilities will likely aid
those wishing to enhance manual
palpatory diagnostic and OMT skills; this
could also aid in the agreement phase of
both intra- and inter-examiner studies.
Furthermore, objective durometer
measurements of documented tissue
texture change closely mirrors
perceptions of clinical improvement in
palpatory motion and tissue texture
characteristics after treatment of OA SD
using HVLA thrust OMT technique.

